Sunday 22 April 2018 ,
Sunday 22 April 2018 ,
Latest News
  • Court sets May 16 for deposition over Rana Plaza collapse case
  • India cabinet clears ordinance on death penalty to child rapists
  • Govt doing ‘foul politics’ over Khaleda’s treatment: BNP
  • Bangladesh took little steps to prosecute abuses, killings by security forces: US
19 March, 2018 00:00 00 AM

FDA approves Cimduo

drugs.com
FDA approves Cimduo

The U.S. Food and Drug Administration (FDA) has approved Cimduo (lamivudine and tenofovir disoproxil fumarate), a combination of two nucleo(t)side reverse transcriptase inhibitors indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection.

Cimduo can cause serious side effects, including:

Too much lactic acid in your blood (lactic acidosis).Lactic acidosis is a serious medical emergency that can lead to death.

Tell your healthcare provider right away if you get any of the following symptoms that could be signs of lactic acidosis:

feel very weak or tired

unusual (not normal) muscle pain

trouble breathing

stomach pain with nausea or vomiting

feel cold, especially in your arms and legs

feel dizzy or lightheaded

have a fast or irregular heartbeat

Severe liver problems. In some cases, severe liver problems can lead to death. Your liver may become large (hepatomegaly) and you may develop fat in your liver (steatosis).

Call your healthcare provider right away if you get any of the following signs or symptoms of liver problems:

your skin or the white part of your eyes turns yellow (jaundice)

dark or “tea-colored” urine

light-colored stools (bowel movements)

loss of appetite for several days or longer

nausea and vomiting

pain, aching, or tenderness on the right side of your stomach-area

Worsening of hepatitis B infection. If you have Human Immunodeficiency Virus type 1 (HIV-1) and hepatitis B Virus (HBV) infection, your HBV may get worse (flare-up) if you stop taking Cimduo. A “flare-up” is when your HBV infection suddenly returns in a worse way than before. Your healthcare provider will test you for HBV infection before you start treatment.

It is not known if Cimduo is safe and effective in people who have both HIV-1 and HBV infection.

Do not run out of this medicine. Refill your prescription or talk to your healthcare provider before your Cimduo is all gone.

Do not stop treatment without first talking to your healthcare provider. If you stop taking Cimduo, your healthcare provider will need to check your health often and do blood tests regularly for several months to check your liver.

New or worse kidney problems, including kidney failure. Your healthcare provider may do blood and urine tests to check your kidneys before and during treatment with Cimduo. Tell your healthcare provider if you get signs and symptoms of kidney problems, including bone pain that does not go away or worsening bone pain, pain in your arms, hands, legs or feet, broken (fractured) bones, muscle pain or weakness.

Cimduo is a prescription medicine that is used with other antiretroviral medicines to treat Human Immunodeficiency Virus-1 (HIV-1) in adults and children weighing at least 35 kg.

HIV-1 is the virus that causes AIDS (Acquired Immune Deficiency Syndrome).

Cimduo contains the prescription medicines lamivudine and tenofovir disoproxil fumarate.

You should not take Cimduo if you:

are allergic to lamivudine, tenofovir disoproxil fumarate, or any of the other ingredients. See the end of this Patient Information leaflet for a complete list of ingredients.

Before you take Cimduo, tell your healthcare provider about all of your medical conditions, including if you:

have liver problems, including hepatitis B or C infection

have kidney problems, including end-stage renal disease (ESRD) that requires dialysis

have bone problems, including a history of bone fractures

are pregnant or plan to become pregnant. It is not known if Cimduo will harm your unborn baby. There is a pregnancy registry for women who take Cimduo during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. Talk to your healthcare provider about how you can take part in this registry.

are breastfeeding or plan to breastfeed. Do not breastfeed if you take Cimduo.

You should not breastfeed if you have HIV-1 because of the risk of passing HIV-1 to your baby.

Talk to your healthcare provider about the best way to feed your baby.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.

Some medicines interact with Cimduo. Cimduo may affect the way other medicines work, and vice versa. Keep a list of your medicines and show it to your healthcare provider and pharmacist when you get a new medicine.

You can ask your healthcare provider or pharmacist for a list of medicines that interact with Cimduo.

Do not start taking a new medicine without telling your healthcare provider. Your healthcare provider can tell you if it is safe to take Cimduo with other medicines.

Take this medicine exactly as your healthcare provider tells you to take it.

Take Cimduo one time each day with or without food.

Do not miss a dose. If you miss a dose, take the missed dose as soon as you remember. If it is almost time for your next dose, do not take the missed dose. Take the next dose at your regular time.

Stay under the care of your healthcare provider during treatment.

Do not run out of this medicine. The virus in your blood may increase and the virus may become harder to treat. When your supply starts to run low, get more from your healthcare provider or pharmacy.

If you take too much or overdose, go to the nearest hospital emergency room right away.

You should avoid taking medicines that contain sorbitol during treatment.

Cimduo side effects

Cimduo may cause serious side effects, including:

Use with interferon and ribavirin-based regimens. Worsening of liver disease that has caused death has happened in people infected with HIV-1 and hepatitis C virus who were taking antiretroviral medicines for HIV-1 and were also being treated for hepatitis C with interferon alfa with or without ribavirin. If you are taking Cimduo and interferon alfa with or without ribavirin, tell your healthcare provider if you have any new symptoms.

Risk of inflammation of the pancreas (pancreatitis). Children may be at risk for developing pancreatitis during treatment with Cimduo if they:

have taken nucleoside analogue medicines in the past

have a history of pancreatitis

have other risk factors for pancreatitis

Call your healthcare provider right away if your child develops signs and symptoms of pancreatitis including severe upper stomach-area pain, with or without nausea and vomiting. Your healthcare provider may tell you to stop giving Cimduo to your child if their symptoms and blood test results show that your child may have pancreatitis.

Bone problems can happen in some people who take Cimduo. Bone problems include bone pain, softening or thinning (which may lead to fractures). Your healthcare provider may need to do tests to check your bones. Tell your healthcare provider if you have any bone pain, pain in your hands or feet, or muscle pain or weakness during treatment.

Changes in your immune system (Immune Reconstitution Syndrome) can happen when you start taking HIV-1 medicines. Your immune system may get stronger and begin to fight infections that have been hidden in your body for a long time. Tell your healthcare provider if you start having new symptoms after starting your HIV-1 medicine.

Changes in body fat can happen in some people who take HIV-1 medicines. These changes may include increased amount of fat in the upper back and neck (“buffalo hump”), breast, and around the main part of your body (trunk). Loss of fat from the legs, arms, and face may also happen. The cause and long-term health effects of these conditions are not known.

The most common side effects include:

headache

pain

depression

diarrhea

rash

Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects.

 

Comments

Most Viewed
Digital Edition
More story
From the Editor

From the Editor

Parkinson’s disease is a slowly progressing, degenerative disorder of the nervous system; Parkinson’s disease has several distinguishing characteristics:…
CDC focused on finding ‘nightmare bacteria’ and preventing their spread

CDC focused on finding ‘nightmare bacteria’ and preventing their spread

Dr. Kelly Arps The Centers for Disease Control and Prevention communicated on Tuesday the early outcomes of their targeted campaign to identify infections…
Stem cell trial aims to cure blindness

Stem cell trial aims to cure blindness

Surgeons in London have carried out a pioneering human embryonic stem cell operation in an ongoing trial to find a cure for blindness for many patients.…
Parkinson’s disease

Parkinson’s disease

Parkinson’s disease (PD) is a neurodegenerative brain disorder that progresses slowly in most people. What this means is that individuals with PD…
Parkinson’s disease: cause and effect

Parkinson’s disease: cause and effect

Parkinson’s Disease is a gradually progressive disorder of the nervous system that causes mainly a loss of motor skills. It usually affects people…
10 early signs of parkinson’s disease

10 early signs of parkinson’s disease

It can be hard to tell if you or a loved one has Parkinson's disease (PD). Below are 10 signs that you might have the disease. No single one of these…
Hand & microsurgery hand injuries and treatments

Hand & microsurgery hand injuries and treatments

The hands are one of the most important parts of human body. Hands are very complex organ with multiple joints, different types of ligaments, tendons…
Universal health care in Bangladesh—promises and perils

Universal health care in Bangladesh—promises and perils

Valid and reliable indicators against which progress towards global targets of 80% coverage of health services and 100% financial protection from catastrophic…
The devastating side effects of antidepressants

The devastating side effects of antidepressants

Jessica Wick Anxiety and depression are all too common in our society — and no one is exempt. Even some of our most well-known celebrities have…
Occupational therapy for parkinson’s disease

Occupational therapy for parkinson’s disease

Parkinson’s is a chronic, insidiously progressing, neurological condition. The most common clinical features are believed to result from the progressive…
IPNA becomes first ever institute in BSMMU

IPNA becomes first ever institute in BSMMU

University Grant Commission (UGC) has approved “Establishment of Institute of Paediatric Neurodisorder and Autism (IPNA)” as full-fledged,…
More than half your body is not human

More than half your body is not human

James Gallagher More than half of your body is not human, say scientists. Human cells make up only 43% of the body's total cell count. The rest are…
FDA approves ZTlido

FDA approves ZTlido

Sorrento Therapeutics Subsidiary, Scilex, receives FDA Approval for Non-Opioid ZTlido (lidocaine topical system) 1.8% for Post-Herpetic Neuralgia Pain…

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting